img

Global Neuromyelitis Optica Therapy Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Neuromyelitis Optica Therapy Market Insights, Forecast to 2034

Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds nerve fibers and helps nerve signals, move from cell to cell. The syndrome can also damage nerve fibers and leave areas of broken-down tissue. In the disease process of NMO, for reasons that aren't yet clear, immune system cells and antibodies attack and destroy myelin cells in the optic nerves and the spinal cord.
Neuromyelitis optica drug is drug used in the treatment of neuromyelitis optica, in this report we focused on Glucocorticoids such as Methylprednisolone and Immunoglobulin such as IVIg.
Market Analysis and InsightsGlobal Neuromyelitis Optica Therapy Market
Global Neuromyelitis Optica Therapy market is expected to reach to US$ 49 million in 2024, with a positive growth of %, compared with US$ 47 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Neuromyelitis Optica Therapy industry is evaluated to reach US$ 60 million in 2029. The CAGR will be 3.4% during 2024 to 2029.
Europe is the largest Neuromyelitis Optica Drug market with about 40% market share. North America is follower, accounting for about 35% market share.
The key players are Pfizer, Fresenius, Teva, Sandoz, Intas, Gyjtrs, NANG KUANG, Tianjin Kingyork, Baxter, CSL, Grifols, Octapharma, CBOP etc. Top 3 companies occupied about 35% market share.
Report Covers
This report presents an overview of global Neuromyelitis Optica Therapy market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Neuromyelitis Optica Therapy market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Pfizer
Fresenius
Teva
Sandoz
Intas
Gyjtrs
NANG KUANG
Tianjin Kingyork
Baxter
CSL
Grifols
Octapharma
CBOP
Segment by Type
Glucocorticoids
Immunotherapies
Other

Segment by Application


Acute Attack
Remission Prophylactic Treatment
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Neuromyelitis Optica Therapy introduction, etc. Neuromyelitis Optica Therapy Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Neuromyelitis Optica Therapy
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuromyelitis Optica Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Glucocorticoids
1.2.3 Immunotherapies
1.2.4 Other
1.3 Market by Application
1.3.1 Global Neuromyelitis Optica Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Acute Attack
1.3.3 Remission Prophylactic Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuromyelitis Optica Therapy Market Perspective (2018-2029)
2.2 Global Neuromyelitis Optica Therapy Growth Trends by Region
2.2.1 Neuromyelitis Optica Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Neuromyelitis Optica Therapy Historic Market Size by Region (2018-2024)
2.2.3 Neuromyelitis Optica Therapy Forecasted Market Size by Region (2024-2029)
2.3 Neuromyelitis Optica Therapy Market Dynamics
2.3.1 Neuromyelitis Optica Therapy Industry Trends
2.3.2 Neuromyelitis Optica Therapy Market Drivers
2.3.3 Neuromyelitis Optica Therapy Market Challenges
2.3.4 Neuromyelitis Optica Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Neuromyelitis Optica Therapy by Players
3.1.1 Global Neuromyelitis Optica Therapy Revenue by Players (2018-2024)
3.1.2 Global Neuromyelitis Optica Therapy Revenue Market Share by Players (2018-2024)
3.2 Global Neuromyelitis Optica Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Neuromyelitis Optica Therapy, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Neuromyelitis Optica Therapy Market Concentration Ratio
3.4.1 Global Neuromyelitis Optica Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuromyelitis Optica Therapy Revenue in 2022
3.5 Global Key Players of Neuromyelitis Optica Therapy Head office and Area Served
3.6 Global Key Players of Neuromyelitis Optica Therapy, Product and Application
3.7 Global Key Players of Neuromyelitis Optica Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuromyelitis Optica Therapy Breakdown Data by Type
4.1 Global Neuromyelitis Optica Therapy Historic Market Size by Type (2018-2024)
4.2 Global Neuromyelitis Optica Therapy Forecasted Market Size by Type (2024-2029)
5 Neuromyelitis Optica Therapy Breakdown Data by Application
5.1 Global Neuromyelitis Optica Therapy Historic Market Size by Application (2018-2024)
5.2 Global Neuromyelitis Optica Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Neuromyelitis Optica Therapy Market Size (2018-2029)
6.2 North America Neuromyelitis Optica Therapy Market Size by Type
6.2.1 North America Neuromyelitis Optica Therapy Market Size by Type (2018-2024)
6.2.2 North America Neuromyelitis Optica Therapy Market Size by Type (2024-2029)
6.2.3 North America Neuromyelitis Optica Therapy Market Share by Type (2018-2029)
6.3 North America Neuromyelitis Optica Therapy Market Size by Application
6.3.1 North America Neuromyelitis Optica Therapy Market Size by Application (2018-2024)
6.3.2 North America Neuromyelitis Optica Therapy Market Size by Application (2024-2029)
6.3.3 North America Neuromyelitis Optica Therapy Market Share by Application (2018-2029)
6.4 North America Neuromyelitis Optica Therapy Market Size by Country
6.4.1 North America Neuromyelitis Optica Therapy Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Neuromyelitis Optica Therapy Market Size by Country (2018-2024)
6.4.3 North America Neuromyelitis Optica Therapy Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Neuromyelitis Optica Therapy Market Size (2018-2029)
7.2 Europe Neuromyelitis Optica Therapy Market Size by Type
7.2.1 Europe Neuromyelitis Optica Therapy Market Size by Type (2018-2024)
7.2.2 Europe Neuromyelitis Optica Therapy Market Size by Type (2024-2029)
7.2.3 Europe Neuromyelitis Optica Therapy Market Share by Type (2018-2029)
7.3 Europe Neuromyelitis Optica Therapy Market Size by Application
7.3.1 Europe Neuromyelitis Optica Therapy Market Size by Application (2018-2024)
7.3.2 Europe Neuromyelitis Optica Therapy Market Size by Application (2024-2029)
7.3.3 Europe Neuromyelitis Optica Therapy Market Share by Application (2018-2029)
7.4 Europe Neuromyelitis Optica Therapy Market Size by Country
7.4.1 Europe Neuromyelitis Optica Therapy Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Neuromyelitis Optica Therapy Market Size by Country (2018-2024)
7.4.3 Europe Neuromyelitis Optica Therapy Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Neuromyelitis Optica Therapy Market Size (2018-2029)
8.2 China Neuromyelitis Optica Therapy Market Size by Type
8.2.1 China Neuromyelitis Optica Therapy Market Size by Type (2018-2024)
8.2.2 China Neuromyelitis Optica Therapy Market Size by Type (2024-2029)
8.2.3 China Neuromyelitis Optica Therapy Market Share by Type (2018-2029)
8.3 China Neuromyelitis Optica Therapy Market Size by Application
8.3.1 China Neuromyelitis Optica Therapy Market Size by Application (2018-2024)
8.3.2 China Neuromyelitis Optica Therapy Market Size by Application (2024-2029)
8.3.3 China Neuromyelitis Optica Therapy Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Neuromyelitis Optica Therapy Market Size (2018-2029)
9.2 Asia Neuromyelitis Optica Therapy Market Size by Type
9.2.1 Asia Neuromyelitis Optica Therapy Market Size by Type (2018-2024)
9.2.2 Asia Neuromyelitis Optica Therapy Market Size by Type (2024-2029)
9.2.3 Asia Neuromyelitis Optica Therapy Market Share by Type (2018-2029)
9.3 Asia Neuromyelitis Optica Therapy Market Size by Application
9.3.1 Asia Neuromyelitis Optica Therapy Market Size by Application (2018-2024)
9.3.2 Asia Neuromyelitis Optica Therapy Market Size by Application (2024-2029)
9.3.3 Asia Neuromyelitis Optica Therapy Market Share by Application (2018-2029)
9.4 Asia Neuromyelitis Optica Therapy Market Size by Region
9.4.1 Asia Neuromyelitis Optica Therapy Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Neuromyelitis Optica Therapy Market Size by Region (2018-2024)
9.4.3 Asia Neuromyelitis Optica Therapy Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Neuromyelitis Optica Therapy Introduction
11.1.4 Pfizer Revenue in Neuromyelitis Optica Therapy Business (2018-2024)
11.1.5 Pfizer Recent Developments
11.2 Fresenius
11.2.1 Fresenius Company Details
11.2.2 Fresenius Business Overview
11.2.3 Fresenius Neuromyelitis Optica Therapy Introduction
11.2.4 Fresenius Revenue in Neuromyelitis Optica Therapy Business (2018-2024)
11.2.5 Fresenius Recent Developments
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva Neuromyelitis Optica Therapy Introduction
11.3.4 Teva Revenue in Neuromyelitis Optica Therapy Business (2018-2024)
11.3.5 Teva Recent Developments
11.4 Sandoz
11.4.1 Sandoz Company Details
11.4.2 Sandoz Business Overview
11.4.3 Sandoz Neuromyelitis Optica Therapy Introduction
11.4.4 Sandoz Revenue in Neuromyelitis Optica Therapy Business (2018-2024)
11.4.5 Sandoz Recent Developments
11.5 Intas
11.5.1 Intas Company Details
11.5.2 Intas Business Overview
11.5.3 Intas Neuromyelitis Optica Therapy Introduction
11.5.4 Intas Revenue in Neuromyelitis Optica Therapy Business (2018-2024)
11.5.5 Intas Recent Developments
11.6 Gyjtrs
11.6.1 Gyjtrs Company Details
11.6.2 Gyjtrs Business Overview
11.6.3 Gyjtrs Neuromyelitis Optica Therapy Introduction
11.6.4 Gyjtrs Revenue in Neuromyelitis Optica Therapy Business (2018-2024)
11.6.5 Gyjtrs Recent Developments
11.7 NANG KUANG
11.7.1 NANG KUANG Company Details
11.7.2 NANG KUANG Business Overview
11.7.3 NANG KUANG Neuromyelitis Optica Therapy Introduction
11.7.4 NANG KUANG Revenue in Neuromyelitis Optica Therapy Business (2018-2024)
11.7.5 NANG KUANG Recent Developments
11.8 Tianjin Kingyork
11.8.1 Tianjin Kingyork Company Details
11.8.2 Tianjin Kingyork Business Overview
11.8.3 Tianjin Kingyork Neuromyelitis Optica Therapy Introduction
11.8.4 Tianjin Kingyork Revenue in Neuromyelitis Optica Therapy Business (2018-2024)
11.8.5 Tianjin Kingyork Recent Developments
11.9 Baxter
11.9.1 Baxter Company Details
11.9.2 Baxter Business Overview
11.9.3 Baxter Neuromyelitis Optica Therapy Introduction
11.9.4 Baxter Revenue in Neuromyelitis Optica Therapy Business (2018-2024)
11.9.5 Baxter Recent Developments
11.10 CSL
11.10.1 CSL Company Details
11.10.2 CSL Business Overview
11.10.3 CSL Neuromyelitis Optica Therapy Introduction
11.10.4 CSL Revenue in Neuromyelitis Optica Therapy Business (2018-2024)
11.10.5 CSL Recent Developments
11.11 Grifols
11.11.1 Grifols Company Details
11.11.2 Grifols Business Overview
11.11.3 Grifols Neuromyelitis Optica Therapy Introduction
11.11.4 Grifols Revenue in Neuromyelitis Optica Therapy Business (2018-2024)
11.11.5 Grifols Recent Developments
11.12 Octapharma
11.12.1 Octapharma Company Details
11.12.2 Octapharma Business Overview
11.12.3 Octapharma Neuromyelitis Optica Therapy Introduction
11.12.4 Octapharma Revenue in Neuromyelitis Optica Therapy Business (2018-2024)
11.12.5 Octapharma Recent Developments
11.13 CBOP
11.13.1 CBOP Company Details
11.13.2 CBOP Business Overview
11.13.3 CBOP Neuromyelitis Optica Therapy Introduction
11.13.4 CBOP Revenue in Neuromyelitis Optica Therapy Business (2018-2024)
11.13.5 CBOP Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Neuromyelitis Optica Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Glucocorticoids
Table 3. Key Players of Immunotherapies
Table 4. Key Players of Other
Table 5. Global Neuromyelitis Optica Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Neuromyelitis Optica Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Neuromyelitis Optica Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Neuromyelitis Optica Therapy Market Share by Region (2018-2024)
Table 9. Global Neuromyelitis Optica Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Neuromyelitis Optica Therapy Market Share by Region (2024-2029)
Table 11. Neuromyelitis Optica Therapy Market Trends
Table 12. Neuromyelitis Optica Therapy Market Drivers
Table 13. Neuromyelitis Optica Therapy Market Challenges
Table 14. Neuromyelitis Optica Therapy Market Restraints
Table 15. Global Neuromyelitis Optica Therapy Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Neuromyelitis Optica Therapy Revenue Share by Players (2018-2024)
Table 17. Global Top Neuromyelitis Optica Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromyelitis Optica Therapy as of 2022)
Table 18. Global Neuromyelitis Optica Therapy Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Neuromyelitis Optica Therapy Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Neuromyelitis Optica Therapy, Headquarters and Area Served
Table 21. Global Key Players of Neuromyelitis Optica Therapy, Product and Application
Table 22. Global Key Players of Neuromyelitis Optica Therapy, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Neuromyelitis Optica Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Neuromyelitis Optica Therapy Revenue Market Share by Type (2018-2024)
Table 26. Global Neuromyelitis Optica Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Neuromyelitis Optica Therapy Revenue Market Share by Type (2024-2029)
Table 28. Global Neuromyelitis Optica Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Neuromyelitis Optica Therapy Revenue Share by Application (2018-2024)
Table 30. Global Neuromyelitis Optica Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Neuromyelitis Optica Therapy Revenue Share by Application (2024-2029)
Table 32. North America Neuromyelitis Optica Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Neuromyelitis Optica Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Neuromyelitis Optica Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Neuromyelitis Optica Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Neuromyelitis Optica Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Neuromyelitis Optica Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Neuromyelitis Optica Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Neuromyelitis Optica Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Neuromyelitis Optica Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Neuromyelitis Optica Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Neuromyelitis Optica Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Neuromyelitis Optica Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Neuromyelitis Optica Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Neuromyelitis Optica Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Neuromyelitis Optica Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Neuromyelitis Optica Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Neuromyelitis Optica Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Neuromyelitis Optica Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Neuromyelitis Optica Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Neuromyelitis Optica Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Neuromyelitis Optica Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Neuromyelitis Optica Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Neuromyelitis Optica Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Neuromyelitis Optica Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Neuromyelitis Optica Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Neuromyelitis Optica Therapy Product
Table 67. Pfizer Revenue in Neuromyelitis Optica Therapy Business (2018-2024) & (US$ Million)
Table 68. Pfizer Recent Developments
Table 69. Fresenius Company Details
Table 70. Fresenius Business Overview
Table 71. Fresenius Neuromyelitis Optica Therapy Product
Table 72. Fresenius Revenue in Neuromyelitis Optica Therapy Business (2018-2024) & (US$ Million)
Table 73. Fresenius Recent Developments
Table 74. Teva Company Details
Table 75. Teva Business Overview
Table 76. Teva Neuromyelitis Optica Therapy Product
Table 77. Teva Revenue in Neuromyelitis Optica Therapy Business (2018-2024) & (US$ Million)
Table 78. Teva Recent Developments
Table 79. Sandoz Company Details
Table 80. Sandoz Business Overview
Table 81. Sandoz Neuromyelitis Optica Therapy Product
Table 82. Sandoz Revenue in Neuromyelitis Optica Therapy Business (2018-2024) & (US$ Million)
Table 83. Sandoz Recent Developments
Table 84. Intas Company Details
Table 85. Intas Business Overview
Table 86. Intas Neuromyelitis Optica Therapy Product
Table 87. Intas Revenue in Neuromyelitis Optica Therapy Business (2018-2024) & (US$ Million)
Table 88. Intas Recent Developments
Table 89. Gyjtrs Company Details
Table 90. Gyjtrs Business Overview
Table 91. Gyjtrs Neuromyelitis Optica Therapy Product
Table 92. Gyjtrs Revenue in Neuromyelitis Optica Therapy Business (2018-2024) & (US$ Million)
Table 93. Gyjtrs Recent Developments
Table 94. NANG KUANG Company Details
Table 95. NANG KUANG Business Overview
Table 96. NANG KUANG Neuromyelitis Optica Therapy Product
Table 97. NANG KUANG Revenue in Neuromyelitis Optica Therapy Business (2018-2024) & (US$ Million)
Table 98. NANG KUANG Recent Developments
Table 99. Tianjin Kingyork Company Details
Table 100. Tianjin Kingyork Business Overview
Table 101. Tianjin Kingyork Neuromyelitis Optica Therapy Product
Table 102. Tianjin Kingyork Revenue in Neuromyelitis Optica Therapy Business (2018-2024) & (US$ Million)
Table 103. Tianjin Kingyork Recent Developments
Table 104. Baxter Company Details
Table 105. Baxter Business Overview
Table 106. Baxter Neuromyelitis Optica Therapy Product
Table 107. Baxter Revenue in Neuromyelitis Optica Therapy Business (2018-2024) & (US$ Million)
Table 108. Baxter Recent Developments
Table 109. CSL Company Details
Table 110. CSL Business Overview
Table 111. CSL Neuromyelitis Optica Therapy Product
Table 112. CSL Revenue in Neuromyelitis Optica Therapy Business (2018-2024) & (US$ Million)
Table 113. CSL Recent Developments
Table 114. Grifols Company Details
Table 115. Grifols Business Overview
Table 116. Grifols Neuromyelitis Optica Therapy Product
Table 117. Grifols Revenue in Neuromyelitis Optica Therapy Business (2018-2024) & (US$ Million)
Table 118. Grifols Recent Developments
Table 119. Octapharma Company Details
Table 120. Octapharma Business Overview
Table 121. Octapharma Neuromyelitis Optica Therapy Product
Table 122. Octapharma Revenue in Neuromyelitis Optica Therapy Business (2018-2024) & (US$ Million)
Table 123. Octapharma Recent Developments
Table 124. CBOP Company Details
Table 125. CBOP Business Overview
Table 126. CBOP Neuromyelitis Optica Therapy Product
Table 127. CBOP Revenue in Neuromyelitis Optica Therapy Business (2018-2024) & (US$ Million)
Table 128. CBOP Recent Developments
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuromyelitis Optica Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Neuromyelitis Optica Therapy Market Share by Type: 2022 VS 2029
Figure 3. Glucocorticoids Features
Figure 4. Immunotherapies Features
Figure 5. Other Features
Figure 6. Global Neuromyelitis Optica Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Neuromyelitis Optica Therapy Market Share by Application: 2022 VS 2029
Figure 8. Acute Attack Case Studies
Figure 9. Remission Prophylactic Treatment Case Studies
Figure 10. Neuromyelitis Optica Therapy Report Years Considered
Figure 11. Global Neuromyelitis Optica Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Neuromyelitis Optica Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Neuromyelitis Optica Therapy Market Share by Region: 2022 VS 2029
Figure 14. Global Neuromyelitis Optica Therapy Market Share by Players in 2022
Figure 15. Global Top Neuromyelitis Optica Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromyelitis Optica Therapy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Neuromyelitis Optica Therapy Revenue in 2022
Figure 17. North America Neuromyelitis Optica Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Neuromyelitis Optica Therapy Market Share by Type (2018-2029)
Figure 19. North America Neuromyelitis Optica Therapy Market Share by Application (2018-2029)
Figure 20. North America Neuromyelitis Optica Therapy Market Share by Country (2018-2029)
Figure 21. United States Neuromyelitis Optica Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Neuromyelitis Optica Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Neuromyelitis Optica Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Neuromyelitis Optica Therapy Market Share by Type (2018-2029)
Figure 25. Europe Neuromyelitis Optica Therapy Market Share by Application (2018-2029)
Figure 26. Europe Neuromyelitis Optica Therapy Market Share by Country (2018-2029)
Figure 27. Germany Neuromyelitis Optica Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Neuromyelitis Optica Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Neuromyelitis Optica Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Neuromyelitis Optica Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Neuromyelitis Optica Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Neuromyelitis Optica Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Neuromyelitis Optica Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Neuromyelitis Optica Therapy Market Share by Type (2018-2029)
Figure 35. China Neuromyelitis Optica Therapy Market Share by Application (2018-2029)
Figure 36. Asia Neuromyelitis Optica Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Neuromyelitis Optica Therapy Market Share by Type (2018-2029)
Figure 38. Asia Neuromyelitis Optica Therapy Market Share by Application (2018-2029)
Figure 39. Asia Neuromyelitis Optica Therapy Market Share by Region (2018-2029)
Figure 40. Japan Neuromyelitis Optica Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Neuromyelitis Optica Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Neuromyelitis Optica Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Neuromyelitis Optica Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Neuromyelitis Optica Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Neuromyelitis Optica Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Neuromyelitis Optica Therapy Market Share by Country (2018-2029)
Figure 50. Brazil Neuromyelitis Optica Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Neuromyelitis Optica Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Neuromyelitis Optica Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Neuromyelitis Optica Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Neuromyelitis Optica Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Neuromyelitis Optica Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Pfizer Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2018-2024)
Figure 57. Fresenius Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2018-2024)
Figure 58. Teva Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2018-2024)
Figure 59. Sandoz Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2018-2024)
Figure 60. Intas Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2018-2024)
Figure 61. Gyjtrs Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2018-2024)
Figure 62. NANG KUANG Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2018-2024)
Figure 63. Tianjin Kingyork Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2018-2024)
Figure 64. Baxter Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2018-2024)
Figure 65. CSL Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2018-2024)
Figure 66. Grifols Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2018-2024)
Figure 67. Octapharma Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2018-2024)
Figure 68. CBOP Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2018-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries